Home
About
Overview
Sharing Data
ORCID
Help
History (7)
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses.
Monoclonal antibody therapy.
Principal Investigator
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells.
Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas.
Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas. Ther Adv Hematol. 2020; 11:2040620720902899.
View in:
PubMed
authors with profiles
Michael Bishop
Peter Riedell